Yi-Hsin Chan Selected Research

Symporters

1/2023	Adverse cardiovascular, limb, and renal outcomes in patients with diabetes after peripheral artery disease revascularization treated with sodium glucose cotransporter 2 inhibitors versus dipeptidyl peptidase-4 inhibitors.
1/2020	Major adverse cardiovascular and limb events in patients with diabetes and concomitant peripheral artery disease treated with sodium glucose cotransporter 2 inhibitor versus dipeptidyl peptidase-4 inhibitor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yi-Hsin Chan Research Topics

Disease

54	Atrial Fibrillation 03/2024 - 01/2016
39	Hemorrhage 03/2024 - 01/2016
27	Stroke (Strokes) 03/2024 - 01/2016
25	Ischemic Stroke 05/2024 - 01/2016
16	Embolism (Embolus) 12/2023 - 01/2016
13	Myocardial Infarction 05/2024 - 01/2016
13	Type 2 Diabetes Mellitus (MODY) 05/2024 - 10/2020
11	Heart Failure 02/2021 - 10/2012
10	Thromboembolism 10/2023 - 10/2018
9	Chronic Renal Insufficiency 12/2023 - 11/2016
9	Intracranial Hemorrhages (Intracranial Hemorrhage) 11/2023 - 01/2016
6	Cardiac Arrhythmias (Arrythmia) 07/2023 - 10/2012
6	Chronic Kidney Failure (Chronic Renal Failure) 03/2023 - 04/2016
6	Diabetes Mellitus 01/2021 - 11/2016
4	Peripheral Arterial Disease 01/2023 - 01/2020
4	Aortic Dissection 01/2023 - 01/2021
4	Ventricular Fibrillation 01/2021 - 10/2015
3	Aortic Aneurysm (Aneurysm, Aortic) 01/2023 - 01/2021
3	Hypertension (High Blood Pressure) 01/2022 - 11/2016
3	Neoplasms (Cancer) 10/2021 - 10/2020
3	Acute Kidney Injury (Acute Renal Failure) 08/2018 - 11/2016
3	Bundle-Branch Block (Fascicular Block) 06/2017 - 03/2013
2	Hypokalemia 04/2024 - 10/2015
2	Venous Thrombosis (Deep-Vein Thrombosis) 12/2023 - 10/2021
2	Aortic Diseases 01/2023 - 01/2021
2	Atrial Remodeling 01/2023 - 10/2021
2	COVID-19 01/2022 - 12/2021
2	Weight Loss (Weight Reduction) 01/2021 - 01/2021
2	Body Weight (Weight, Body) 01/2021 - 01/2021
2	Cardiovascular Diseases (Cardiovascular Disease) 11/2020 - 01/2016
2	Ischemia 01/2020 - 09/2016
2	Vascular Diseases (Vascular Disease) 01/2019 - 11/2016
2	Transient Ischemic Attack 01/2019 - 11/2016
2	Intracranial Embolism 01/2018 - 01/2016
1	Hyperkalemia 04/2024
1	Carotid Stenosis (Carotid Artery Stenosis) 03/2024
1	Dementia (Dementias) 10/2023
1	Marfan Syndrome (Marfan's Syndrome) 01/2023
1	Foot Ulcer 01/2023
1	Fibrosis (Cirrhosis) 01/2023
1	Interstitial Lung Diseases (Interstitial Lung Disease) 11/2022
1	Frailty 01/2022
1	Anemia 01/2022
1	Thrombocytopenia (Thrombopenia) 01/2022
1	Aneurysm (Aneurysms) 01/2021
1	Chronic Limb-Threatening Ischemia 01/2021
1	Heart Arrest (Cardiac Arrest) 01/2021

Drug/Important Bio-Agent (IBA)

38	AnticoagulantsIBA 03/2024 - 01/2016
33	Warfarin (Coumadin)FDA LinkGeneric 03/2024 - 01/2016
22	Vitamin K FDA Link 03/2024 - 01/2016
15	RivaroxabanIBA 12/2023 - 01/2016
14	Dabigatran FDA Link 12/2023 - 01/2016
11	Glucose (Dextrose)FDA LinkGeneric 05/2024 - 01/2020
10	SodiumIBA 05/2024 - 01/2020
9	Sodium-Glucose Transport ProteinsIBA 05/2024 - 01/2020
9	N(4)-oleylcytosine arabinosideIBA 03/2024 - 01/2019
8	apixabanIBA 02/2024 - 01/2018
5	CreatinineIBA 02/2024 - 01/2021
5	edoxabanIBA 12/2023 - 01/2019
4	PotassiumIBA 04/2024 - 10/2015
4	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 03/2024 - 11/2017
4	CalciumIBA 01/2021 - 10/2015
4	omega-Chloroacetophenone (Mace)IBA 01/2021 - 01/2016
3	Glucagon-Like Peptide-1 Receptor AgonistsIBA 03/2024 - 01/2022
3	FluoroquinolonesIBA 01/2023 - 01/2021
3	Hemoglobins (Hemoglobin)IBA 01/2023 - 11/2020
3	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2021 - 04/2016
3	Angiotensin Receptor AntagonistsIBA 01/2021 - 04/2016
3	ApaminIBA 01/2018 - 10/2015
2	Sodium-Glucose Transporter 2 InhibitorsIBA 04/2024 - 03/2024
2	SymportersIBA 01/2023 - 01/2020
2	Clopidogrel (Plavix)FDA Link 01/2023 - 10/2021
2	Factor Xa (Coagulation Factor Xa)IBA 11/2022 - 11/2019
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2021
1	Proteins (Proteins, Gene)FDA Link 07/2023
1	Adrenergic Receptors (Adrenergic Receptor)IBA 07/2023
1	salicylhydroxamic acid (SHAM)IBA 01/2023
1	Phosphates (Orthophosphate)IBA 01/2023
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 10/2021
1	TicagrelorIBA 10/2021
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 10/2021
1	Factor Xa InhibitorsIBA 10/2021
1	AntithrombinsIBA 10/2021
1	L-Type Calcium Channels (Dihydropyridine Receptor)IBA 10/2021
1	Dobutamine FDA LinkGeneric 02/2021
1	Simendan (Levosimendan)IBA 02/2021
1	DiureticsIBA 01/2021
1	LumicanIBA 01/2021
1	Insulin (Novolin)FDA Link 01/2021
1	Interleukin-17 (Interleukin 17)IBA 01/2021
1	AminopropionitrileIBA 01/2021
1	APTIBA 01/2021

Therapy/Procedure

7	Surgical Amputation (Amputations) 05/2024 - 09/2016
7	Therapeutics 03/2024 - 01/2011
4	Cardiac Resynchronization Therapy 06/2017 - 03/2013
3	Stents 12/2021 - 10/2012
2	Percutaneous Coronary Intervention 01/2023 - 05/2020
2	Renal Dialysis (Hemodialysis) 10/2021 - 12/2018
1	Secondary Prevention 01/2023
1	Drug Therapy (Chemotherapy) 01/2022